The return of thalidomide: new uses and renewed concerns.
Communicable Diseases (Leprosy Group), WHO.
V
V
Pannikar
D000014:Abnormalities, Drug-Induced / Q000517:prevention & control; D014943:Global Health; D006291:Health Policy; D006801:Humans; D007917:Leprostatic Agents / Q000009:adverse effects*; D007918:Leprosy / Q000188:drug therapy*; D013723:Teratogens; D013792:Thalidomide / Q000009:adverse effects*; D014944:World Health Organization
D007917:Leprostatic Agents; D013723:Teratogens; D013792:Thalidomide